Cancer genetic risk assessment for individuals at risk of familial breast cancer

Cochrane Database of Systematic Reviews

Volumn 2022, Issue 1, 2012, Pages

  Hilgart, Jennifer S ^a   Coles, Bernadette ^b   Iredale, Rachel ^c  

^a Portland VA Research Foundation   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF GLAMORGAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; FAMILY HEALTH; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SERVICE; GENETICS; HUMAN; MENTAL STRESS; META ANALYSIS; ORGANIZATION AND MANAGEMENT; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT;

BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SERVICES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; STRESS, PSYCHOLOGICAL;

EID: 84861312730     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003721.pub3     Document Type: Review

References (130)

1. Bowen D, McTiernan A, Burke W, Powers D, Pruski J, Durfy S, et al. Participation in breast cancer risk counselling among women with a family history. Cancer Epidemiology, Biomarkers and Prevention 1999;8(7):7. x-wiley/crsRef/19550995
2. Bowen DJ, Burke W, McTiernan A, Yasui Y, Anderson MR. Breast cancer risk counseling improves women's functioning. Patient Education and Counseling 2004;53:79-86. x-wiley/crsRef/19550996
3. Bowen DJ, Burke W, Culver J, Press N, Crystal S. Effects of counseling Ashkenazi Jewish women about breast cancer risk. Cultural DIversity and Ethnic Minority Psychology 2006;12(1):45-56. x-wiley/crsRef/19550998
4. Brain K, Gray J, Norman P, France E, Anglim C, Barton G, et al. Randomized trial of a specialist genetic assessment service for familial breast cancer. Journal of the National Cancer Institute 2000;92(16):1345-51. x-wiley/crsRef/19551000
5. Brain K, Norman P, Gray J, Rogers C, Mansel R, Harper P. A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk. British Journal of Cancer 2002;86:233-8. x-wiley/crsRef/19551001
6. Braithwaite D, Sutton S, Mackay J, Stein J, Emery J. Development of a risk assessment tool for women with a family history of breast cancer. Cancer Detection and Prevention 2005;29:433-9. x-wiley/crsRef/19551003
7. Fry A, Cull A, Appleton S, Rush R, Holloway S, Gorman D, et al. A randomised controlled trial of breast cancer genetic services in South East Scotland: psychological impact. British Journal of Cancer 89;4:653-9. x-wiley/crsRef/19551005
8. Helmes AW, Culver J, Bowen DJ. Results of a randomized study of telephone versus in-person breast cancer risk counseling. Patient Education and Counseling 2006;64:96-103. x-wiley/crsRef/19551007
9. Matloff ET, Moyer A, Shannon KM, Niendorf KB, Nananda F. Healthy women with a family history of breast cancer: Impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making. Journal of Women's Health 2006;15(7):843-56. x-wiley/crsRef/19551009
10. Young D, McLeish L, Sullivan F, Pitkethly M, Reis M, Goudie D, et al. Familial breast cancer: management of 'lower risk' referrals. British Journal of Cancer 2006;95:974-8. x-wiley/crsRef/19551011
11. Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. Journal of the National Cancer Institute 2010;102(10):680-91. x-wiley/crsRef/19551013
12. Appleton S, Watson M, Rush R, Garcia-Minaur S, Porteous M, Campbell J, et al. A randomised controlled trial of a psychoeducational intervention for women at increased risk of breast cancer. British Journal of Cancer 2004;90:41-7. x-wiley/crsRef/19551015
13. Armstrong K, Weber B, Ubel PA, Peters N, Holmes J, Achwartz JS. Individualized survival curves improve satisfaction with cancer risk management decisions in women with BRCA1/2 mutations. Journal of Clinical Oncology 2005;23(36):9319-28. x-wiley/crsRef/19551017
14. Barcenas CH, Hosain GM, Arun B, Zong J, Zhou X, Chen J, et al. Assessing BRCA carrier probabilities in extended families. Journal of Clinical Oncology 2006;24(3):354-60. x-wiley/crsRef/19551019
15. Bellcross CA, Lemke AA, Pape LS, Tess AL, Meisner LT. Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population. Genetics in Medicine 2009;11(11):783-9. x-wiley/crsRef/19551021
16. Bluman LG, Rimer BK, Berry DA, Borstelmann N, Iglehart JD, Regan K, et al. Attitudes, knowledge, beliefs, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. Journal of Clinical Oncology 1999;17(3):1040-6. x-wiley/crsRef/19551023
17. Bowen DJ, Burke W, Yasui Y, McTiernan A, McLeran D. Effects of risk counseling on interest in breast cancer genetic testing for lower risk women. Genetics in Medicine 2002;4(5):359-65. x-wiley/crsRef/19551025
18. Brain K, Norman P, Gray J, Mansel R. Anxiety and adherence to breast self-examination in women with a family history of breast cancer. Psychosomatic Medicine 1999;61:181-7. x-wiley/crsRef/19551027
19. Brain K, Gray J, Norman P, Parsons E, Clarke A, Rogers C, et al. Why do women attend familial breast cancer clinics? Journal of Medical Genetics 2000;37:197-202. x-wiley/crsRef/19551029
20. Butow PN, Tucker K, Meiser B, Barrett A. Genetic counselling of women from high risk breast cancer families: a randomised trial of audiotape provision and interactive analysis. University of Sydney Cancer Research Fund 1998. x-wiley/crsRef/19551031
21. Calzone KA, Prindiville SA, Jourkiv O, Jenkins J, DeCarvalho M, Wallerstedt DB, et al. Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer. Journal of Clinical Oncology 2005;23(15):3455-64. x-wiley/crsRef/19551033
22. Cameron LD, Diefenbach MA. Responses to information about psychological consequences of genetic testing for breast cancer susceptibility: influences of cancer worry and risk perceptions. Journal of Health Psychology 2001;6(1):47-59. x-wiley/crsRef/19551035
23. Campbell H, Holloway S, Cetnarskyj R, Anderson E, Rush R, Fry A, et al. Referrals of women with a family history of breast cancer from primary care to cancer genetics services in South-East Scotland. British Journal of Cancer 2003;89(9):1650-6. x-wiley/crsRef/19551037
24. Charles S, Kessler L, Stopfer JE, Domchek S, Halbert CH. Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Education & Counseling 2006;63(1-2):169-204. x-wiley/crsRef/19551039
25. Cohen D, Barton G, Gray J, Brain K. Health economics and genetic service development: a familial cancer genetic example. Familial Cancer 2004;3(1):61-7. x-wiley/crsRef/19551041
26. Cull A, Miller H, Porterfield T, Mackay J, Anderson E, Steel M. The use of videotaped information in cancer genetic counselling: a randomised evaluation study. British Journal of Cancer 1998;77(5):830-7. x-wiley/crsRef/19551043
27. Daly MB, Montgomery S, Harrop-Stein C, Costalas JW, Gillespie D, Masny A. Psychological outcomes of high risk women in a cancer genetics education and counseling program. In: Unknown (Abstracts - Poster Presentations). 1998. x-wiley/crsRef/19551045
28. Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, et al. The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. British Journal of Cancer 2007;97(4):486-93. x-wiley/crsRef/19551047
29. Gray SW, O'Grady C, Karp L, Smith D, Schwartz JS, Hornik RC, et al. Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention 2009;18(4):1303-11. x-wiley/crsRef/19551049
30. *Green MJ, Biesecker BB, McInerney AM, Mauger D, Fost N. An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. American Journal of Medical Genetics 2001;103:16-23. x-wiley/crsRef/19551051
31. Green MJ, McInerney AM, Biesecker BB, Fost N. Education about genetic testing susceptibility: patient preferences for a computer program or genetic counselor. American Journal of Medical Genetics 2001;103:24-31. x-wiley/crsRef/19551052
32. Green MJ, Swoger J, Del Bene F, Wittbrodt J, Stelzer EH. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. JAMA 2004;305(5686):442-52. x-wiley/crsRef/19551054
33. Green MJ, Peterson SK, Baker MW, Friedman LC, Harper GR, Rubinstein WS, et al. Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions. Genetics in Medicine 2005;7(4):221-9. x-wiley/crsRef/19551056
34. Halbert CH, Kessler L, Troxel AB, Stopfer JE, Domchek S. Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial. Public Health Genomics. 2010;13(7-8):440-8. x-wiley/crsRef/19551058
35. Hall J, Gray S, A'Hern R, Shanley S, Watson M, Kash K, et al. Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines. Familial Cancer 2009;8(1):5-13. x-wiley/crsRef/19551060
36. Halverson PK, Mays GP, Rimer BK, Lerman C, Audrain J, Kalzuny AD. Adoption of a health education intervention for family members of breast cancer patients. American Journal of Preventive Medicine 2000;18(3):189-98. x-wiley/crsRef/19551062
37. Helgeson VS, Cohen S, Schulz R, Yasko J. Long-term effects of educational and peer discussion group interventions on adjustment to breast cancer. Health Psychology 2001;20(5):387-92. x-wiley/crsRef/19551064
38. Hopwood P, Wonderling D, Watson M, Cull A, Douglas F, Cole T, et al. A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes. British Journal of Cancer 2004;91:884-92. x-wiley/crsRef/19551066
39. Hoskins CN, Haber J, Budin WC, Cartwright-Alcarese F, Kowlaski MO, Panke J, et al. Breast cancer: education, counselling, and adjustment - a pilot study. Psychological Reports 2001;89(3):677-704. x-wiley/crsRef/19551068
40. Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer 2006;107(8):1769-76. x-wiley/crsRef/19551070
41. Hurt GJ, McQuellon RP, Michielutte R, Conrad DM, Carter S, Anderson H. Risk assessment of first-degree relatives of women with breast cancer: a feasibility study. Oncology Nursing Forum 2001;28(7):1097-104. x-wiley/crsRef/19551072
42. Jibaja ML, Kingery P, Neff NE, Smith Q, Bowman J, Holcomb JD. Tailored, interactive soap operas for breast cancer education of high risk Hispanic women. Journal of Cancer Education 2000;15(4):237-42. x-wiley/crsRef/19551074
43. Lerman C, Rimer BK, Daly M, Lustbader E, Sands C, Balshem A, et al. Recruiting high risk women into a breast cancer health promotion trial. Cancer Epidemiology, Biomarkers and Prevention 1994;3(3):271-6. x-wiley/crsRef/19551076
44. Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, et al. Effects of individualized breast cancer risk counselling: a randomised trial. Journal of the National Cancer Institute 1995;87(4):286-92. x-wiley/crsRef/19551078
45. Lerman C, Schwartz MD, Miller SM, Daly M, Sands C, Rimer BK. A randomised trial of breast cancer risk counselling: Interacting effects of counselling, educational levels, and coping style. Health Psychology 1996;15(2):75-83. x-wiley/crsRef/19551080
46. Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. Journal of the National Cancer Institute 1997;89(2):148-57. x-wiley/crsRef/19551082
47. Lerman C, Hughes C, Benkendorf JL, Biesecker B, Kerner J, Willison J, et al. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiology, Biomarkers and Prevention 1999;8:361-7. x-wiley/crsRef/19551084
48. Lobb EA, Butow PN, Meiser B, Barratt A, Gaff CM, Young MA, et al. Tailoring communication in consultations with women from high risk breast cancer families. British Journal of Cancer 2002;87(5):502-8. x-wiley/crsRef/19551086
49. Lobb E, Butow PN, Meiser B, Barratt A, Kirk J, Gattas M, et al. The use of audiotapes in consultations with women from high risk breast cancer families. Journal of Medical Genetics 2002;39:697-703. x-wiley/crsRef/19551088
50. Miedzybrodzka Z, Hamilton NM, Gregory H, Milner B, Frade I, Sinclair T, et al. teaching undergraduates about familial breast cancer: comparison of a computer assisted learning (CAL) package with a traditional tutorial approach. European Journal of Human Genetics 2001;9(12):953-6. x-wiley/crsRef/19551090
51. Miller SM, Fleisher L, Roussi P, Buzaglo JS, Schnoll R, Slater E, et al. Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service. Journal of Health Communication 2005;10(Suppl 1):119-36. x-wiley/crsRef/19551092
52. Miron A, Schildkraut JM, Rimer BK, Winer EP, Sugg Skinner C, Futreal PA, et al. Testing for hereditary breast and ovarian cancer in the Southeastern United States. Annals of Surgey 2000;231(5):624-34. x-wiley/crsRef/19551094
53. Ormond KE, Pergament E, Fine BA. Pre-screening education in multiple marker screening programs: the effect on patient anxiety and knowledge. Journal of Genetic Counseling 1996;5(2):69-80. x-wiley/crsRef/19551096
54. Rahm AK, Sukhanova A, Ellis J, Mouchawar J. Increasing utilization of cancer genetic counseling services using a patient navigator model. Journal of Genetic Counseling 2007;16(2):171-7. x-wiley/crsRef/19551098
55. Ramirez AG, Miller AR, Gallion K, San Miguel de Majors S, Chalela P, García Arámburo S. Testing three different cancer genetics registry recruitment methods with Hispanic cancer patients and their family members previously registered in local cancer registries in Texas. Community Genetics 2008;11(4):215-23. x-wiley/crsRef/19551100
56. Roshanai AH, Rosenquist R, Lampic C, Nordin K. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives? - -a randomized study. Acta Oncologica 2009;48(7):999-1009. x-wiley/crsRef/19551102
57. Roussi P, Sherman KA, Miller S, Buzaglo J, Daly M, Taylor A, et al. Enhanced counselling for women undergoing BRCA1/2 testing: Impact on knowledge and psychological distress-results from a randomised clinical trial. Psychology & Health 2010;25(4):401-15. x-wiley/crsRef/19551104
58. Schwartz MD, Lerman C, Audrain J, Cella D, Rimer B, Stefanek M, et al. The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients. Annals of Behavioural Medicine 1998;20(1):7-12. x-wiley/crsRef/19551106
59. Schwartz MD, Rimer BK, Daly M, Sands C, Lerman C. A randomised trial of breast cancer risk counselling: the impact on self-reported mammography use. American Journal of Public Health 1999;89(6):924-6. x-wiley/crsRef/19551108
60. Schwartz MD, Benkendorf J, Lerman C, Isaacs C, Ryan-Robertson A, Johnson L. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish Women. Cancer 2001;92(4):932-40. x-wiley/crsRef/19551110
61. Schwartz MD, Valdimarsdottir HB, DeMarco TA, Peshkin BN, Lawrence W, Rispoli J, et al. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychology 2009;28(1):11-9. x-wiley/crsRef/19551112
62. Skinner CS, Schildkraut JM, Berry D, Calingaert B, Marcom PK, Sugarman J, et al. Pre-counseling education materials for BRCA testing: does tailoring make a difference? Genetic Testing 2002;6(1):93-105. x-wiley/crsRef/19551114
63. Stoddard AM, Fox SA, Costanza ME, Lane DS, Anderson MR, Urban N, et al. Effectiveness of telephone counseling for mammography: results from five randomized trials. Preventive Medicine 2002;34(1):90-9. x-wiley/crsRef/19551116
64. Street RL jr, Van Order A, Bramson R, Manning T. Preconsultation education promoting breast cancer screening: Does the choice of media make a difference? Journal of Cancer Education 1998;13(3):152-61. x-wiley/crsRef/19551118
65. Torrance N, Mollison J, Wordsworth S, Gray J, Miedzybrodzka Z, Haites N, et al. Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials. British Journal of Cancer 2006;95(4):435-44. x-wiley/crsRef/19551120
66. Van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, et al. Randomised trial of a decision aid and its timing for women being tested for BRCA1/2 mutation. British Journal of Cancer 2004;90(2):333-42. x-wiley/crsRef/19551122
67. Van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC. Randomized trial of a shared-decision making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. Journal of Clinical Oncology 2004;22(16):3293-301. x-wiley/crsRef/19551124
68. Venne VL, Hamann HA. Successful use of peer educators for sharing genetic information. Journal of Genetic Counseling 2007;16(4):515-25. x-wiley/crsRef/19551126
69. Wade-Walsh M. Women receiving genetic counseling for breast cancer risk: Cancer worry, psychological distress, and risk recall accuracy. Dissertation Abstracts Internationa: Section B: the Sciences & Engineering 2001;61(7b):2865. x-wiley/crsRef/19551128
70. Wakefield CE, Meiser B, Homewood J, Peate M, Taylor A, Lobb E, et al. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Research & Treatment 2008;107(2):289-301. x-wiley/crsRef/19551130
71. Wakefield CE, Meiser B, Homewood J, Taylor A, Gleeson M, Williams R, et al. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. Psycho-oncology 2008;17(8):844-54. x-wiley/crsRef/19551132
72. Wang C, Gonzalez R, Milliron KJ, Strecher VJ, Merajver SD. Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process. American Journal of Medical Genetics. Part A 2005;134A(1):66-73. x-wiley/crsRef/19551134
73. Watson M. Communication of information on risk of familial breast cancer: a controlled randomised trial of audiotaped consultations. Psycho-Oncology 1996;2(3suppl):19. x-wiley/crsRef/19551136
74. Watson M, Duivier V, Wade-Walsh M, Ashley S, Davidson J, Papaikonomou M, et al. Family history of breast cancer: what do women understand and recall about their genetic risk? Journal of Medical Genetics 1998;35(9):731-8. x-wiley/crsRef/19551138
75. Watson E, Clements A, Yudkin P, Rose P, Bukach C, Mackay J, et al. Evaluation of impact of two educational interventions on GP management of familial breast / ovarian cancer cases: a cluster randomised controlled trial. British Journal of General Practice 2001;51(471):817-21. x-wiley/crsRef/19551140
76. Wevers MR, Ausems MG, Verhoef S, Bleiker EM, Hahn DE, Hogervorst FB, et al. Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: Design of a multicenter randomized clinical trial. BMC Cancer 2011;11:6. x-wiley/crsRef/19551142
77. Wilson BJ, Torrance N, Mollison J, Wordsworth S, Gray JR, Haites NE, et al. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions. Health Technology Assessment 2005;9(3):iii-iv. x-wiley/crsRef/19551144
78. Wilson BJ, Torrance N, Mollison J, Watson MS, Douglas A, Miedzybrodzka Z, et al. Cluster randomized trial of a multifaceted primary care decision-support intervention for inherited breast cancer risk. Family Practice 2006;23(5):537-44. x-wiley/crsRef/19551146
79. Ockhuysen-Vermey CF, Henneman L, Van Asperen CJ, Oosterwijk JC, Menko FH, Timmermans DR. Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling. BMC Cancer 2008;8:283. x-wiley/crsRef/19551148
80. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics 2003;72:1117-30.
81. Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA 2008;299:194–201.
82. Bennett P, Phelps C, Brain K, Hood K, Gray J. A randomized controlled trial of a brief self-help coping intervention designed to reduce distress when awaiting genetic risk information. Journal of Psychosomatic Research 2007;63:59-64.
83. Bober SL, Hoke LA, Duda RB, Tung NM. Recommendation recall and satisfaction after attending breast/ovarian cancer risk counseling. Journal of Genetic Counseling 2007;16(6):755-62.
84. Bowen D, McTiernan A, Burke W, Powers D, Pruski J, Durfy S, et al. Participation in breast cancer risk counselling among women with a family history. Cancer Epidemiology, Biomarkers and Prevention 1999;8(7):7.
85. Brain K, Norman P, Gray J, Rogers C, Mansel R, Harper P. A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk. British Journal of Cancer 2002;86:233-8.
86. Braithwaite D, Sutton S, Henry Smithson W, Emery J. Internet-based risk assessment and decision support for the management of familial cancer in primary care: a survey of GP's attitudes and intentions. Family Practice 2002;19(6):587-90.
87. Braithwaite D, Emery J, Walter F, Prevost T, Sutton S. Psychological impact of genetic counselling for familial cancer: a systematic review and meta-analysis. Journal of the National Cancer Institute 2004;96(2):122-33.
88. Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Familial Cancer 2006;5:61-75.
89. Champion VL. Instrument development for health belief model constructs. ANS Advanced Nursing Science 1984;6:73-85.
90. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. Journal of Clinical Oncology 2007;25(11):1329-33.
91. Coehlo JJ, Arnold A, Nayler J, Tischkowitz M, MacKay J. An assessment of the efficiency of cancer genetic counselling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations. European Journal of Cancer 2005;41(15):2257-61.
92. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: An introductory report. Psychological Medicine 1983;13:595-605.
93. Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1 mutation carriers. American Journal of Human Genetics 1995;56(1):265-71.
94. Eeles RA, Murday VA. The cancer family clinic. In: Eeles RA, Easton DF, Ponder BAJ, Eng C, editors(s). Genetic predisposition to cancer. 2nd edition. London: Arnold, 2004:391-403.
95. Elwyn G, Iredale R, Gray J. Reactions to GPs to a triage-controlled referral system for cancer genetics. Family Practice 2002;19:65-71.
96. Ford D, Easton DF, Bishop DT. Risks of cancer in BRCA1 mutation carriers. Lancet 1994;343:692-5.
97. Ford D, Easton D, Stratton M, Narad S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. American Journal of Human Genetics 1998;62:676-89.
98. Fry A, Campbell H, Gudmunsdottir H, Rush R, Porteous M, Gorman D, et al. GPs' views on their role in cancer genetics services and current practice. Family Practice 1999;16(5):468-74.
99. Goldberg D, Williams P. A user's guide to the General Health Questionnaire. Windsor: NFER-Nelson, 1988.
100. Gray J, Brain K, Iredale R, Alderman J, France E, Hughes H. A pilot study of telegenetics. Journal of Telemedicine and Telecare 2000;6(4):245-7.
101. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. Linkage of early-onset familial breast cancer. To chromosome 17q21. Science 1990;250:1684-9.
102. Helmes AW, Bowen DJ, Bowden R, Bengel J. Predictors of participation in genetic research in a primary care physician network. Cancer Epidemiology, Biomarkers and Prevention 2000;9:1377-9.
103. Higgins JP, Altman DG. Assessing Risk of Bias in Included Studies. In: Higgins JP, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Chichester, UK: John Wiley & Sons, Ltd, 2008.
104. Hopwood P, Keeling F, Long A, Pool C, Evans G, Howell A. Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psycho-Oncology 1998;7(5):402-12.
105. Iredale R, Brain K, Edwards L, Gray J, France E. The information and support needs of women at high risk of familial breast and ovarian cancer: how can cancer genetics services give patients what they want? Familial Cancer 2003;2:119-21.
106. Julian-Reynier CM, Bouchard LJ, Evans DG, Eisinger FA, Foulkes WD, Kerr B, et al. Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French and Canadian women. Cancer 2001;92(4):959-68.
107. Lea DH, Johnson JL, Ellingwood S, Allan W, Patel A, Smith R. Telegenetics in Maine: successful clinical and educational service delivery model developed from a 3 year pilot project. Genetics in Medicine 2005;7(1):21-7.
108. Lerman C, Trock B, Rimer BK, Jepson C, Brody D. Psychological side effects of breast cancer screening. Health Psychology 1991;10(4):259-67.
109. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioural implications of abnormal mammograms. Annals of Internal Medicine 1991;114:657-61.
110. Lerman C, Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Research and Treatment 1993;287:145-55.
111. Lucassen A, Watson E, Harcourt J, Rose P, O'Grady J. Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate cases. Family Practice 2001;18(2):135-40.
112. McPherson K, Steel CM, Dixon JM. Breast cancer: epidemiology, risk factors and genetics. BMJ 2000;321:624-8.
113. Meiser B, Halliday JL. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Social Science & Medicine 2002;54:1463-70.
114. Meropol NJ, Daly MB, Vig HS, Manion FJ, Manne SL, Mazar C, et al. Delivery of Internet-based cancer genetic counselling services to patients’ homes:a feasibility study. Journal of Telemedicine and Telecare 2011;17:36-40.
115. Phelps C, Platt K, France L, Gray J, Iredale R. Delivering information about cancer genetics via letter to patients at low and moderate risk of familial cancer: a pilot study in Wales. Familial Cancer 2004;3:55-9.
116. Phelps C, Bennett P, Jones H, Hood K, Brain K, Murray A. The development of a cancer genetic-specific measure of coping: the GRACE. Psycho-Oncology 2010;19(8):847-54.
117. Phinney JS. The Multigroup Ethnic Identity Measure: A new scale for use with diverse groups. Journal of Adolescent Research 1992;7:156-76.
118. Pocock SJ. Clinical trials - a practical approach. Chichester: Wiley & Sons, 1983.
119. Rahman N, Stratton MR. The genetics of breast cancer susceptibility. Annual Review of Genetics 1998;32:95-121.
120. Scott S, Prior L, Wood F, Gray J. Repositioning the patient: the implications of being 'at risk'. Social Science and Medicine 2005;60(8):1869-79.
121. Shiloh S, Avdor O, Goodman RM. Satisfaction with genetic counselling: dimensions measurement. American Journal of Medical Genetics 1990;37:522-9.
122. Spielberger CD. Manual of the State-Trait Anxiety Inventory. Palo Alto (CA): Consulting Psychologists Press, 1983.
123. Struewing JP, Hartage P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine 1997;326:401-8.
124. Tempest V, Iredale R, Gray J, France L, Anstey S, Stweard J. Pedigree construction and disease confirmation: a feasibility study exploring the role of non-clinical personnel. European Journal of Human Genetics 2005;13:1063-70.
125. Van Roosmalen MS, Stalmeier PFM, Verhoef LCG, Hoekstra-Weebers JEHM, Oosterwijk JC, Hoogerbrugge N, et al. Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. American Journal of Medical Genetics 2003;12A(4):346-55.
126. Whittemore AS. Risk of breast cancer in carriers of BRCA gene mutations. New England Journal of Medicine 1997;11:788-9.
127. Wonderling D, Hopwood P, Cull A, Douglas F, Watson M, Burn J, et al. A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics. British Journal of Cancer 2001;85(2):166-70.
128. Wood ME, Mullineaux L, Rahm AK, Fairclough D, Wenzel L. Impact of BRCA1 testing on women with cancer: a pilot study. Genetic Testing 2000;4(3):265-72.
129. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al. Localization of a breast cancer susceptibility gene BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90.
130. Sivell S, Iredale R, Gray J, Coles B. Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No: CD003721. [DOI: 10.1002/14651858.CD003721.pub2]